Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

NCT00800709 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Memantine

Sponsor

Shanghai Mental Health Center

Collaborators

[object Object]